280 related articles for article (PubMed ID: 31604668)
21. Comparison of outcomes between the one-step and two-step sentinel lymph node mapping techniques in endometrial cancer.
Kim YN; Eoh KJ; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
Int J Gynecol Cancer; 2020 Mar; 30(3):318-324. PubMed ID: 31992601
[TBL] [Abstract][Full Text] [Related]
22. Sentinel lymph node biopsy for robotic-assisted endometrial cancer staging: further improvement of perioperative outcomes.
Casarin J; Multinu F; Tortorella L; Cappuccio S; Weaver AL; Ghezzi F; Cilby W; Kumar A; Langstraat C; Glaser G; Mariani A
Int J Gynecol Cancer; 2020 Jan; 30(1):41-47. PubMed ID: 31780567
[TBL] [Abstract][Full Text] [Related]
23. Surgical and oncological outcomes of sentinel lymph node sampling in elderly patients with intermediate to high-risk endometrial carcinoma.
Matanes E; Eisenberg N; Mitric C; Yasmeen A; Ismail S; Raban O; Cantor T; Knigin D; Lau S; Salvador S; Gotlieb W; Kogan L
Int J Gynecol Cancer; 2022 Jul; 32(7):875-881. PubMed ID: 35680137
[TBL] [Abstract][Full Text] [Related]
24. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
25. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.
Rossi EC; Kowalski LD; Scalici J; Cantrell L; Schuler K; Hanna RK; Method M; Ade M; Ivanova A; Boggess JF
Lancet Oncol; 2017 Mar; 18(3):384-392. PubMed ID: 28159465
[TBL] [Abstract][Full Text] [Related]
26. The impact of the type of nodal assessment on prognosis in patients with high-intermediate and high-risk ESMO/ESGO/ESTRO group endometrial cancer. A multicenter Italian study.
Buda A; Restaino S; Di Martino G; De Ponti E; Monterossi G; Dinoi G; Magni S; Quagliozzi L; Dell'Orto F; Ciccarone F; Lamanna M; Scambia G; Landoni F; Fanfani F
Eur J Surg Oncol; 2018 Oct; 44(10):1562-1567. PubMed ID: 30077521
[TBL] [Abstract][Full Text] [Related]
27. Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomy.
Leitao MM; Zhou QC; Gomez-Hidalgo NR; Iasonos A; Baser R; Mezzancello M; Chang K; Ward J; Chi DS; Long Roche K; Sonoda Y; Brown CL; Mueller JJ; Gardner GJ; Jewell EL; Broach V; Zivanovic O; Dowdy SC; Mariani A; Abu-Rustum NR
Gynecol Oncol; 2020 Jan; 156(1):147-153. PubMed ID: 31780238
[TBL] [Abstract][Full Text] [Related]
28. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
[TBL] [Abstract][Full Text] [Related]
29. Long-term survival outcomes in high-risk endometrial cancer patients undergoing sentinel lymph node biopsy alone versus lymphadenectomy.
Capozzi VA; Rosati A; Maglietta G; Vargiu V; Scarpelli E; Cosentino F; Sozzi G; Chiantera V; Ghi T; Scambia G; Berretta R; Fanfani F
Int J Gynecol Cancer; 2023 Jul; 33(7):1013-1020. PubMed ID: 37068852
[TBL] [Abstract][Full Text] [Related]
30. Precise lymph node biopsy for endometrial cancer confined to the uterus: Analysis of 43 clinical cases.
Shi XL; Chen S; Guo GD; Yang YL; Tong KM; Cao W; Huang LL; Zhang YR
Taiwan J Obstet Gynecol; 2024 May; 63(3):369-374. PubMed ID: 38802200
[TBL] [Abstract][Full Text] [Related]
31. Sentinel lymph node intraoperative analysis in endometrial cancer.
Bellaminutti S; Bonollo M; Gasparri ML; Clivio L; Migliora P; Mazzucchelli L; Papadia A
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3199-3205. PubMed ID: 32815026
[TBL] [Abstract][Full Text] [Related]
32. Can risk groups accurately predict non-sentinel lymph node metastasis in sentinel lymph node-positive endometrial cancer patients? A Turkish Gynecologic Oncology Group Study (TRSGO-SLN-004).
Altin D; Taskin S; Tokgozoglu N; Vatansever D; Guler AH; Gungor M; Tasci T; Turan H; Kahramanoglu I; Yalcin I; Celik C; Kose F; Ortac F; Arvas M; Ayhan A; Taskiran C
J Surg Oncol; 2021 Feb; 123(2):638-645. PubMed ID: 33259650
[TBL] [Abstract][Full Text] [Related]
33. The Impact of Sentinel Node-Mapping in Staging High-Risk Endometrial Cancer.
Baiocchi G; Mantoan H; Kumagai LY; Gonçalves BT; Badiglian-Filho L; de Oliveira Menezes AN; Faloppa CC; De Brot L; da Costa AABA
Ann Surg Oncol; 2017 Dec; 24(13):3981-3987. PubMed ID: 29058141
[TBL] [Abstract][Full Text] [Related]
34. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
Backes FJ; Cohen D; Salani R; Cohn DE; O'Malley DM; Fanning E; Suarez AA; Fowler JM
Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614
[TBL] [Abstract][Full Text] [Related]
35. The prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment.
Cosgrove CM; Cohn DE; Rhoades J; Felix AS
Gynecol Oncol; 2019 Jun; 153(3):505-510. PubMed ID: 30935714
[TBL] [Abstract][Full Text] [Related]
36. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
37. Comparison of oncological outcomes between sentinel lymph node biopsy and complete lymphadenectomy for endometrial cancer.
Makroum AA; Lee YJ; Lee JY; Nam EJ; Kim S; Kim SW; Kim YT
J Obstet Gynaecol Res; 2023 Aug; 49(8):2118-2125. PubMed ID: 37286510
[TBL] [Abstract][Full Text] [Related]
38. Sentinel lymph node (SLN) isolated tumor cells (ITCs) in otherwise stage I/II endometrioid endometrial cancer: To treat or not to treat?
Backes FJ; Felix AS; Plante M; Grégoire J; Sullivan SA; Rossi EC; Tanner EJ; Stewart KI; Soliman PT; Holloway RW; Abu-Rustum NR; Leitao MM
Gynecol Oncol; 2021 May; 161(2):347-352. PubMed ID: 33678480
[TBL] [Abstract][Full Text] [Related]
39. Assessment of Sentinel Lymph Node Biopsy vs Lymphadenectomy for Intermediate- and High-Grade Endometrial Cancer Staging.
Cusimano MC; Vicus D; Pulman K; Maganti M; Bernardini MQ; Bouchard-Fortier G; Laframboise S; May T; Hogen LF; Covens AL; Gien LT; Kupets R; Rouzbahman M; Clarke BA; Mirkovic J; Cesari M; Turashvili G; Zia A; Ene GEV; Ferguson SE
JAMA Surg; 2021 Feb; 156(2):157-164. PubMed ID: 33175109
[TBL] [Abstract][Full Text] [Related]
40. Does sentinel node mapping impact morbidity and quality of life in endometrial cancer?
Goncalves BT; Dos Reis R; Ribeiro R; Moretti-Marques R; Schamme FK; Oliveira GS; Tsunoda AT; Alvarenga-Bezerra V; Lopes A; Pastore CBP; Kumagai LY; Faloppa CC; Mantoan H; Badiglian-Filho L; De Brot L; Andrade CEMC; Baiocchi G
Int J Gynecol Cancer; 2023 Oct; 33(10):1548-1556. PubMed ID: 37699707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
